UBS Group Reaffirms Sell Rating for M.D.C. (MDC)

UBS Group reissued their sell rating on shares of M.D.C. (NYSE:MDC) in a research note issued to investors on Wednesday morning, 99wallstreet.com reports. UBS Group currently has a $32.00 price target on the construction company’s stock, up from their previous price target of $30.00.

MDC has been the topic of a number of other research reports. KeyCorp restated a hold rating on shares of M.D.C. in a report on Tuesday, September 26th. Zacks Investment Research upgraded M.D.C. from a sell rating to a hold rating in a report on Wednesday, October 4th. ValuEngine lowered M.D.C. from a strong-buy rating to a buy rating in a report on Thursday, November 2nd. Finally, Citigroup dropped their target price on M.D.C. from $37.00 to $34.00 and set a neutral rating on the stock in a report on Friday, November 3rd. Four equities research analysts have rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company. The stock has a consensus rating of Hold and a consensus target price of $30.33.

M.D.C. (NYSE:MDC) traded down $0.72 during mid-day trading on Wednesday, hitting $33.97. The stock had a trading volume of 334,141 shares, compared to its average volume of 511,433. M.D.C. has a 52 week low of $25.87 and a 52 week high of $37.45. The company has a quick ratio of 2.60, a current ratio of 9.45 and a debt-to-equity ratio of 0.65. The company has a market capitalization of $1,950.00, a price-to-earnings ratio of 12.22, a PEG ratio of 0.87 and a beta of 1.38.

M.D.C. (NYSE:MDC) last posted its earnings results on Thursday, November 2nd. The construction company reported $1.16 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.61 by $0.55. M.D.C. had a return on equity of 11.66% and a net margin of 6.09%. The company had revenue of $586.30 million for the quarter, compared to analyst estimates of $595.05 million. During the same quarter last year, the company earned $0.54 earnings per share. The company’s revenue for the quarter was up 1.4% on a year-over-year basis. research analysts expect that M.D.C. will post 2.69 EPS for the current year.

In related news, Director Herbert T. Buchwald sold 28,350 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $31.52, for a total transaction of $893,592.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director David Siegel sold 2,500 shares of the stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $31.83, for a total value of $79,575.00. The disclosure for this sale can be found here. Company insiders own 25.30% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of the stock. Acadian Asset Management LLC increased its position in shares of M.D.C. by 54.1% during the fourth quarter. Acadian Asset Management LLC now owns 443,507 shares of the construction company’s stock valued at $14,139,000 after acquiring an additional 155,618 shares during the last quarter. Alpha Windward LLC increased its position in shares of M.D.C. by 11.6% during the fourth quarter. Alpha Windward LLC now owns 16,200 shares of the construction company’s stock valued at $516,000 after acquiring an additional 1,680 shares during the last quarter. Schwab Charles Investment Management Inc. increased its position in M.D.C. by 5.2% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 328,247 shares of the construction company’s stock worth $10,465,000 after buying an additional 16,258 shares during the last quarter. Louisiana State Employees Retirement System increased its position in M.D.C. by 14.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 19,300 shares of the construction company’s stock worth $615,000 after buying an additional 2,436 shares during the last quarter. Finally, Nisa Investment Advisors LLC increased its position in M.D.C. by 8.0% in the fourth quarter. Nisa Investment Advisors LLC now owns 34,267 shares of the construction company’s stock worth $1,092,000 after buying an additional 2,537 shares during the last quarter. 74.15% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This piece was posted by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of international trademark and copyright law. The correct version of this piece can be accessed at https://www.com-unik.info/2018/01/18/ubs-group-reaffirms-sell-rating-for-m-d-c-mdc.html.

M.D.C. Company Profile

M.DC Holdings, Inc is engaged in two primary operations, including homebuilding and financial services. The Company’s segments include West, including segments located in Arizona, California, Nevada and Washington; Mountain, including segments located in Colorado and Utah; East, including segments located in Virginia, Florida and Maryland, which includes Pennsylvania and New Jersey; mortgage operations, including HomeAmerican Mortgage Corporation, and Other, which includes Allegiant Insurance Company, Inc, StarAmerican Insurance Ltd., American Home Insurance Agency, Inc and American Home Title and Escrow Company.

Analyst Recommendations for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit